Aller au contenu principal

 Articles scientifiques

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Auteurs : Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart-Gebhart M, Flamen P, Di Cosimo S
Année : 2013
Journal : J. Nucl. Med.
Volume : 54(11)
Pages : 1862-8

Optimizing taxane use in MBC in the emerging era of targeted chemotherapy.

Auteurs : Von Minckwitz G, Martin M, Wilson G, Alba E, Schmidt M, Biganzoli L, Awada A
Année : 2013
Journal : Crit Rev Oncol Hematol
Volume : 85(3)
Pages : 315-31

Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP).

Auteurs : Ades F, de Azambuja E, Daugaard G, Ameye L, Moulin C, Paesmans M, De Jong D, Decoster L, De Greve J, Ismael G, Møller AK, Piccart-Gebhart M, Awada A
Année : 2013
Journal : J Chemother
Volume : 25(4)
Pages : 239-46

Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer.

Auteurs : Baselga J, Gómez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, Pêgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, Melezínková H, Awada A
Année : 2013
Journal : J. Clin. Oncol.
Volume : 31(20)
Pages : 2586-92

Imbalance between supply and need of medical oncologists in Belgium

Auteurs : Dhondt V, Benahmed A, De Wever L, Dirix L, de Valeriola D
Année : 2013
Journal : Belgian J Medical Oncology
Volume : 7(2)
Pages : 38-45

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

Auteurs : Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, Hamade E, Daher A, Hussein N, Eldirani R, Berri F, Vanhamme L, Burny A, Martiat P, Rouas R, Badran B
Année : 2013
Journal : J Transl Med
Volume : 11(1)
Pages : 31

Clinical practice-changing trials: the HERA study paradigm.

Auteurs : Zardavas D, Ades F, de Azambuja E
Année : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(11)
Pages : 1249-56

Performance and abnormal cell flagging comparisons of three automated blood cell counters: Cell-Dyn Sapphire, DxH-800, and XN-2000.

Auteurs : Hotton J, Broothaers J, Swaelens C, Cantinieaux B
Année : 2013
Journal : Am J. Clin. Pathol.
Volume : 140(6)
Pages : 845-52

Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Auteurs : Aftimos P, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F
Année : 2013
Journal : Int J Oncol
Volume : 43(3)
Pages : 919-26

Contributions of SPECT/CT imaging to the lymphoscintigraphic investigations of the lower limb lymphedema.

Auteurs : Baulieu F, Bourgeois P, Maruani A, Belgrado JP, Tauveron V, Lorette G, Vaillant L
Année : 2013
Journal : Lymphology
Volume : 46(3)
Pages : 106-19

Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature.

Auteurs : Dumitrescu C, Lossignol D
Année : 2013
Journal : Case Rep Oncol Med
Volume : 2013
Pages : 154674

Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states.

Auteurs : Ades F, Senterre C, de Azambuja E, Sullivan R, Popescu R, Parent F, Piccart-Gebhart M
Année : 2013
Journal : Ann Oncol
Volume : 24(11)
Pages : 2897-902

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

Auteurs : De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P, Gil T, Marreaud S, Daugaard G, Skoneczna I, Collette S, Lorent J, de Wit R, Sylvester R
Année : 2012
Journal : J. Clin. Oncol.
Volume : 30(2)
Pages : 191-9

Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.

Auteurs : Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Immunol. Lett.
Volume : 146(1-2)
Pages : 50-6

Le souhait d’aide psychologique des patients âgés atteints d’un cancer.

Auteurs : Libert Y, Merckaert I, Dubruille S, Razavi D
Année : 2012
Journal : Psychooncology
Volume : 6
Pages : 29-32

Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Auteurs : Najar M, Raicevic G, Kazan HF, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pages : 1188-98

Role and interpretation of FDG-PET/CT in HIV patients with fever of unknown origin: a prospective study.

Auteurs : Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S
Année : 2012
Journal : J Int AIDS Soc
Volume : 15(4)
Pages : 18107

Decision-making in oncology: a selected literature review and some recommendations for the future.

Auteurs : Ménard C, Merckaert I, Razavi D, Libert Y
Année : 2012
Journal : Curr Opin Oncol
Volume : 24(4)
Pages : 381-90

Assessment of the intrinsic pluripotency of mesoderm-derived stem cells from different niches.

Auteurs : De Kock J, Najar M, Bolleyn J, Al Battah F, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V
Année : 2012
Journal : ALTEX
Volume : 29
Pages : 31-9

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Auteurs : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Année : 2012
Journal : Lung Cancer
Volume : 77(3)
Pages : 605-610